• Clinlcal Guidelines & Expert Consensu •
SCMR white paper: Interpretation of rapid CMR for clinical indications
Cite this article as: XIANG X R, ZHAO S H. SCMR white paper: Interpretation of rapid CMR for clinical indications[J]. Chin J Magn Reson Imaging, 2023, 14(7): 1-4. DOI:10.12015/issn.1674-8034.2023.07.001.
| [Abstract] Despite decades of accruing evidence supporting the clinical utility of cardiovascular magnetic resonance (CMR), adoption of CMR in routine practice remains limited in many regions of the world. Historic longer scan time hinder improved access to CMR in some patients, and there is an urgent need to incorporate this technology into standardized protocols to answer clinical questions in practice. Based on the latest white paper of the Society for Cardiovascular Magnetic Resonance, combined with the latest research progress, this paper interpreted the common clinical indications, infrastructures, workflow, and extension techniques of basic 30 min or shorter CMR exam, for promoting the global scope of its application and extension. |
| [Keywords] cardiovascular magnetic resonance；magnetic resonance imaging；cardiovascular disease；clinical indication；expert consensus |
XIANG Xiaorui
ZHAO Shihua*
MR Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
Corresponding author: Zhao SH, E-mail: cjr.zhaoshihua@vip.163.com
Conflicts of interest None.
| ACKNOWLEDGMENTS National Key Research and Development Program of China (No. 2021YFF0501400, 2021YFF0501404); Key Project of National Natural Science Foundation of China (No. 81930044). |
| Received 2022-08-22 |
| Accepted 2023-06-28 |
| DOI: 10.12015/issn.1674-8034.2023.07.001 |
| Cite this article as: XIANG X R, ZHAO S H. SCMR white paper: Interpretation of rapid CMR for clinical indications[J]. Chin J Magn Reson Imaging, 2023, 14(7): 1-4. DOI:10.12015/issn.1674-8034.2023.07.001. |
[1]
AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION TASK FORCE ON EXPERT CONSENSUS DOCUMENTS, HUNDLEY W G, BLUEMKE D A, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents[J]. Circulation, 2010, 121(22): 2462-2508.
DOI:
10.1161/CIR.0b013e3181d44a8f.
[2]
WRITING COMMITTEE MEMBERS, GULATI M, LEVY P D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines[J/OL]. J Am Coll Cardiol, 2021, 78(22): e187-e285 [2022-08-21]. https://pubmed.ncbi.nlm.nih.gov/34756653/.
DOI:
10.1016/j.jacc.2021.07.053.
[3]
DOHERTY J U, KORT S, MEHRAN R, et al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease: a report of the American college of cardiology appropriate use criteria task force, American association for thoracic surgery, American heart association, American society of echocardiography, American society of nuclear cardiology, heart rhythm society, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, society for cardiovascular magnetic resonance, and the society of thoracic surgeons[J]. J Nucl Cardiol, 2019, 26(4): 1392-1413.
DOI:
10.1007/s12350-019-01751-7.
[4]
RAMAN S V, MARKL M, PATEL A R, et al. 30-minute CMR for common clinical indications: a Society for Cardiovascular Magnetic Resonance white paper[J/OL]. J Cardiovasc Magn Reson, 2022, 24(1): 13 [2022-08-21]. https://pubmed.ncbi.nlm.nih.gov/35232470/.
DOI:
10.1186/s12968-022-00844-6.
[5]
BUSTIN A, FUIN N, BOTNAR R M, et al. From compressed-sensing to artificial intelligence-based cardiac MRI reconstruction[J/OL]. Front Cardiovasc Med, 2020, 7: 17 [2022-08-21]. https://pubmed.ncbi.nlm.nih.gov/32158767/.
DOI:
10.3389/fcvm.2020.00017.
[6]
LEINER T, BENNINK E, MOL C P, et al. Bringing AI to the clinic: blueprint for a vendor-neutral AI deployment infrastructure[J/OL]. Insights Imaging, 2021, 12(1): 11 [2022-08-21]. https://insightsimaging.springeropen.com/articles/10.1186/s13244-020-00931-1.
DOI:
10.1186/s13244-020-00931-1.
[7]
SCHNEIDER A, CRUZ G, MUNOZ C, et al. Whole-heart non-rigid motion corrected coronary MRA with autofocus virtual 3D iNAV[J/OL]. Magn Reson Imaging, 2022, 87: 169-176 [2022-08-21]. https://pubmed.ncbi.nlm.nih.gov/34999163/.
DOI:
10.1016/j.mri.2022.01.007.
[8]
VAN WANING J I, CALISKAN K, CHELU R G, et al. Diagnostic cardiovascular magnetic resonance imaging criteria in noncompaction cardiomyopathy and the yield of genetic testing[J]. Can J Cardiol, 2021, 37(3): 433-442.
DOI:
10.1016/j.cjca.2020.05.021.
[9]
OMMEN S R, MITAL S, BURKE M A, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines[J/OL]. Circulation, 2020, 142(25): e533-e557 [2022-08-21]. https://pubmed.ncbi.nlm.nih.gov/33215938/.
DOI:
10.1161/CIR.0000000000000938.
[10]
PETERZAN M A, RIDER O J, ANDERSON L J. The role of cardiovascular magnetic resonance imaging in heart failure[J/OL]. Cardiac Fail Rev, 2016: 115 [2022-08-21]. https://www.cfrjournal.com/articles/role-cardiovascular-magnetic-resonance-imaging-heart-failure.
DOI:
10.15420/cfr.2016.2.2.115.
[11]
SATOH H, SANO M, SUWA K, et al. Distribution of late gadolinium enhancement in various types of cardiomyopathies: significance in differential diagnosis, clinical features and prognosis[J]. World J Cardiol, 2014, 6(7): 585-601.
DOI:
10.4330/wjc.v6.i7.585.
[12]
GAZTANAGA J, PARUCHURI V, ELIAS E, et al. Prognostic value of late gadolinium enhancement in nonischemic cardiomyopathy[J]. Am J Cardiol, 2016, 118(7): 1063-1068.
DOI:
10.1016/j.amjcard.2016.06.059.
[13]
ILES L M, ELLIMS A H, LLEWELLYN H, et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis[J]. Eur Heart J Cardiovasc Imaging, 2015, 16(1): 14-22.
DOI:
10.1093/ehjci/jeu182.
[14]
JURLANDER R, MILLS H L, ESPERSEN K I, et al. Screening relatives in arrhythmogenic right ventricular cardiomyopathy: yield of imaging and electrical investigations[J]. Eur Heart J Cardiovasc Imaging, 2020, 21(2): 175-182.
DOI:
10.1093/ehjci/jez204.
[15]
ANDREINI D, DELLO RUSSO A, PONTONE G, et al. CMR for identifying the substrate of ventricular arrhythmia in patients with normal echocardiography[J]. JACC Cardiovasc Imaging, 2020, 13(2Pt 1): 410-421.
DOI:
10.1016/j.jcmg.2019.04.023.
[16]
RAJIAH P S, FRANÇOIS C J, LEINER T. Cardiac MRI: state of the art[J/OL]. Radiology, 2023, 307(3): e223008 [2022-08-21]. https://pubmed.ncbi.nlm.nih.gov/37039684/.
DOI:
10.1148/radiol.223008.
[17]
EMRICH T, HALFMANN M, SCHOEPF U J, et al. CMR for myocardial characterization in ischemic heart disease: state-of-the-art and future developments[J/OL]. Eur Radiol Exp, 2021, 5(1): 14 [2022-08-21]. https://pubmed.ncbi.nlm.nih.gov/33763757/.
DOI:
10.1186/s41747-021-00208-2.
[18]
PONTONE G, GUARICCI A I, ANDREINI D, et al. Prognostic benefit of cardiac magnetic resonance over transthoracic echocardiography for the assessment of ischemic and nonischemic dilated cardiomyopathy patients referred for the evaluation of primary prevention implantable cardioverter-defibrillator therapy[J/OL]. Circ Cardiovasc Imaging, 2016, 9(10): e004956 [2022-08-21]. https://pubmed.ncbi.nlm.nih.gov/27729359/.
DOI:
10.1161/CIRCIMAGING.115.004956.
[19]
NAGEL E, GREENWOOD J P, MCCANN G P, et al. Magnetic resonance perfusion or fractional flow reserve in coronary disease[J]. N Engl J Med, 2019, 380(25): 2418-2428.
DOI:
10.1056/NEJMoa1716734.
[20]
VINCENTI G, MASCI P G, MONNEY P, et al. Stress perfusion CMR in patients with known and suspected CAD: prognostic value and optimal ischemic threshold for revascularization[J]. JACC Cardiovasc Imaging, 2017, 10(5): 526-537.
DOI:
10.1016/j.jcmg.2017.02.006.
[21]
PEZEL T, GAROT P, KINNEL M, et al. Prognostic value of stress cardiovascular magnetic resonance in asymptomatic patients without known coronary artery disease[J].Eur Radiol, 2021, 31(8): 6172-6183.
DOI:
10.1007/s00330-021-08078-3.
[22]
FERREIRA V M, SCHULZ-MENGER J, HOLMVANG G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations[J]. J Am Coll Cardiol, 2018, 72(24): 3158-3176.
DOI:
10.1016/j.jacc.2018.09.072.
[23]
KRAMER C M, BARKHAUSEN J, BUCCIARELLI-DUCCI C, et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update[J/OL]. J Cardiovasc Magn Reson, 2020, 22(1): 17 [2022-08-21]. https://pubmed.ncbi.nlm.nih.gov/32089132/.
DOI:
10.1186/s12968-020-00607-1.
[24]
RAJIAH P, BOLEN M A. Cardiovascular MR imaging at 3 T: opportunities, challenges, and solutions[J]. RadioGraphics, 2014, 34(6): 1612-1635.
DOI:
10.1148/rg.346140048.
[25]
MESSROGHLI D R, MOON J C, FERREIRA V M, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)[J/OL]. J Cardiovasc Magn Reson, 2017, 19(1): 75 [2022-08-21]. https://pubmed.ncbi.nlm.nih.gov/28992817/.
DOI:
10.1186/s12968-017-0389-8.
[26]
MARCUS F I, MCKENNA W J, SHERRILL D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria[J]. Circulation, 2010, 121(13): 1533-1541.
DOI:
10.1161/CIRCULATIONAHA.108.840827.
[27]
OTTO C M, NISHIMURA R A, BONOW R O, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines[J/OL]. Circulation, 2021, 143(5): e35-e71 [2022-08-21]. https://pubmed.ncbi.nlm.nih.gov/33332149/.
DOI:
10.1161/CIR.0000000000000932.
